(Q48161354)

9 February 2018

title

Ganglioside treatment in the recovery of the DA nigrostriatal system in different experimental conditions (English)

1 reference

9 February 2018

author name string

Consolazione A

series ordinal

1

1 reference

9 February 2018

Toffano G

series ordinal

2

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 January 1988

1 reference

9 February 2018

Annals of the New York Academy of Sciences

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

9 February 2018

volume

515

1 reference

9 February 2018

page(s)

395-402

1 reference

9 February 2018

CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Dorsal root ganglia and nerve growth factor: a model for understanding the mechanism of GM1 effects on neuronal repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Ganglioside GM1 overcomes serum inhibition of neuritic outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Gangliosides minimize behavioral deficits and enhance structural repair after brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitransections of the nigro-striatal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

The functional recovery of damaged brain: The effect of GM1 monosialoganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Electrophysiological evidence for the existence of crossed nigrostriatal fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Triiodothyronine enhances the morphological maturation of dopaminergic neurons from fetal mouse hypothalamus cultured in serum-free medium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

Reduction of cerebral edema with GM1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB33016.X

10.1111/J.1749-6632.1988.TB33016.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018